Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Devatis Inc., priced at $11.4609 per EA under NDC 73043001405. Its NADAC has been published 36 times since Jul 9, 2025.
FDA first approved this application on Apr 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
140 mg/1
Manufacturer
Devatis Inc.NDC
73043001405
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/9/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207658FDA Approved
4/26/2017
TE Code
AB
On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 36 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4609 per EA |
|---|---|
| All-time high | $11.4609 (Mar 11, 2026) |
| All-time low | $11.4609 (Jul 9, 2025) |
| 52-week high | $11.4609 |
| 52-week low | $11.4609 |
| Median price | $11.4609 |
| Average price | $11.4609 |
| Largest weekly change | 0.0% (Jul 16, 2025) |
| Weeks tracked | 36 |
| Tracking since | Jul 9, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Devatis Inc., is $11.4609 per EA (NDC 73043001405), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Jul 9, 2025, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $11.4609 (Jul 9, 2025) to a high of $11.4609 (Mar 11, 2026), with a median of $11.4609 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $10.7251 per EA — about 6% below TEMOZOLOMIDE 140 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 73043001405) is labeled by Devatis Inc., and CMS classifies it as a generic product.